144 related articles for article (PubMed ID: 22070411)
1. Tubal ligation and survival of ovarian cancer patients.
Zhang M; Holman CD
J Obstet Gynaecol Res; 2012 Jan; 38(1):40-7. PubMed ID: 22070411
[TBL] [Abstract][Full Text] [Related]
2. Body mass index in relation to ovarian cancer survival.
Zhang M; Xie X; Lee AH; Binns CW; Holman CD
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1307-10. PubMed ID: 15894691
[TBL] [Abstract][Full Text] [Related]
3. Tubal ligation and the risk of ovarian carcinoma.
Cornelison TL; Natarajan N; Piver MS; Mettlin CJ
Cancer Detect Prev; 1997; 21(1):1-6. PubMed ID: 9043756
[TBL] [Abstract][Full Text] [Related]
4. The effect of tubal ligation on the incidence of epithelial cancer of the ovary.
Koch M; Starreveld AA; Hill GB; Jenkins H
Cancer Detect Prev; 1984; 7(4):241-5. PubMed ID: 6488215
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
[TBL] [Abstract][Full Text] [Related]
6. Influence of reproductive factors on mortality after epithelial ovarian cancer diagnosis.
Robbins CL; Whiteman MK; Hillis SD; Curtis KM; McDonald JA; Wingo PA; Kulkarni A; Marchbanks PA
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2035-41. PubMed ID: 19589914
[TBL] [Abstract][Full Text] [Related]
7. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
Rosenblatt KA; Thomas DB
Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):933-5. PubMed ID: 8922304
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
9. Green tea consumption enhances survival of epithelial ovarian cancer.
Zhang M; Lee AH; Binns CW; Xie X
Int J Cancer; 2004 Nov; 112(3):465-9. PubMed ID: 15382073
[TBL] [Abstract][Full Text] [Related]
10. Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer.
Kjaerbye-Thygesen A; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):798-803. PubMed ID: 16614126
[TBL] [Abstract][Full Text] [Related]
11. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
Panici PB; Maggioni A; Hacker N; Landoni F; Ackermann S; Campagnutta E; Tamussino K; Winter R; Pellegrino A; Greggi S; Angioli R; Manci N; Scambia G; Dell'Anna T; Fossati R; Floriani I; Rossi RS; Grassi R; Favalli G; Raspagliesi F; Giannarelli D; Martella L; Mangioni C
J Natl Cancer Inst; 2005 Apr; 97(8):560-6. PubMed ID: 15840878
[TBL] [Abstract][Full Text] [Related]
12. Anthropometry and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Ness RB; Allen GO
Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and risk of epithelial ovarian cancer.
Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
[TBL] [Abstract][Full Text] [Related]
14. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
15. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
16. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
[TBL] [Abstract][Full Text] [Related]
17. ErbB-3 predicts survival in ovarian cancer.
Tanner B; Hasenclever D; Stern K; Schormann W; Bezler M; Hermes M; Brulport M; Bauer A; Schiffer IB; Gebhard S; Schmidt M; Steiner E; Sehouli J; Edelmann J; Läuter J; Lessig R; Krishnamurthi K; Ullrich A; Hengstler JG
J Clin Oncol; 2006 Sep; 24(26):4317-23. PubMed ID: 16896008
[TBL] [Abstract][Full Text] [Related]
18. Tubal ligation and fatal ovarian cancer in a large prospective cohort study.
Miracle-McMahill HL; Calle EE; Kosinski AS; Rodriguez C; Wingo PA; Thun MJ; Heath CW
Am J Epidemiol; 1997 Feb; 145(4):349-57. PubMed ID: 9054239
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
[TBL] [Abstract][Full Text] [Related]
20. Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer.
Paulsen T; Kaern J; Kjaerheim K; Haldorsen T; Tropé C
Gynecol Oncol; 2006 Sep; 102(3):447-52. PubMed ID: 16516277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]